Search

everythinglearnresearchcommunity

for

Search:↓

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Further trials are needed to explore the efficacy of triamcinolone acetonide in dermatology.

The inhibitor affects androgen metabolism but not ovarian function.

Two L-PRP treatments improve hair density in mild to moderate alopecia.

Trilostane helped a dog with an adrenal tumor feel better and stay healthy.

AC5 improves hair loss and hair quality with high satisfaction rates.

CONSORT improves trial reporting but doesn't assess bias.

Testosterone and finasteride improve body composition in men with spinal cord injury.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Abatacept may help some people with alopecia areata regrow hair.

Laser technologies improve medical treatments and outcomes.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Baricitinib shows promise for treating alopecia areata with mild side effects.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

TrichoScan needs optimization as it underestimated hair density by 38.9% compared to manual counting.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Low-level red light therapy can shorten eye length in some myopic children.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Countries with stricter cultures had fewer COVID-19 cases and deaths, paranoia is linked to false memories, psychosocial intervention works as well with or without antipsychotic drugs for young people with psychosis, smartphones can detect changes in behavior indicating illness relapse, and recruitment agents show regional and gender biases.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Li2CO3 improved skin disease in a mouse model of Focal Dermal Hypoplasia without toxicity.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.